Financials
- Market Capitalization 49.6 M
- Employee 8
- Founded 2018
- CEO N/A
- Website www.impactbiomedinc.com
- Headquarter Nevada, United States
- FIGI BBG01JFZG014
- Industry Case Farmaceutiche - Generali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
0.52
Rapporto prezzo/fatturato
513.45
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4066 | OSTX OS Therapies Incorporated Common Stock | 1.69 USD | +3.05% | +9.03% | +9.74% | +46.96% | 77.95 M USD | ||
| 4176 | EXOZ eXoZymes Inc. - Common Stock | 6.73 USD | -6.14% | -6.27% | +37.63% | -30.62% | 62.46 M USD | ||
| 4289 | SCLX Scilex Holding Company - Common Stock | 5.50 USD | +1.29% | -3.68% | -16.03% | -32.35% | 46.71 M USD | ||
| 4428 | MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.77 USD | +2.67% | -3.75% | -1.28% | -43.80% | 32.36 M USD |